Eye Disease

Edit

Ethyreal Bio Emerges from Stealth with $101 Million in Financing to Advance ETHY-001, a Potentially Best-in-Class Anti-TSHR Antibody for Thyroid Eye Disease and Graves’ Disease (Avoro Capital Advisors LLC)

Public Technologies 16 Jun 2026

Ethyreal's lead program, ETHY-001, is a monoclonal antibody designed to block autoantibody-mediated activation of the thyroid stimulating hormone receptor (TSHR), the shared pathogenic driver of Graves' disease (GD) and thyroid eye disease (TED).

Edit

Minghui Pharmaceutical Presents Compelling Phase I/II Results for MHB018A, a Novel Subcutaneous Anti-IGF-1R Antibody for Thyroid Eye Disease, in an Oral Presentation at ENDO 2026, the Endocrine Society's Annual Meeting

PR Newswire 16 Jun 2026

MHB018A demonstrated outstanding clinical activity in both active and chronic thyroid eye disease At 450 mg Q4W, MHB018A achieved a remarkable 81% proptosis response at Week 12 in active TED and a 76% ...

Edit

DKSH and Long Chau Join Forces to Bring Dry Eye Disease Screening to Vietnamese Communities Nationwide (DKSH Holding AG)

Public Technologies 15 Jun 2026

Jun 15, 2026 DKSH and Long Chau Join Forces to Bring Dry Eye Disease Screening to Vietnamese Communities Nationwide ... Dry eye disease is a growing public health concern in Vietnam but often remains ...

Edit

New Exhibit Explores Far-Reaching Impact of an Ancient Eye Disease (AAO - American Academy of Ophthalmology)

Public Technologies 20 May 2026

New Exhibit Explores Far-Reaching Impact of an Ancient Eye Disease ... Iconic, fictional stories aside, this feared blinding eye disease has served a critical narrative plot point across human history since 800 B.C.E ... www.aao.org/museum-of-the-eye.

Edit

Eyes that photosynthesize: Scientists plant a cure for dry eye disease

Phys Dot Org 18 May 2026

What if eyes could use light to heal themselves? Drawing inspiration from how plants harness sunlight, researchers at the National University of Singapore (NUS) are pioneering a revolutionary treatment for dry eye disease.

Edit

NUS study finds photosynthesis could treat dry eye disease

Straits Times 17 May 2026

The team engineered ...

Edit

Eyes that photosynthesise: NUS scientists plant a cure for dry eye disease

The Berkshire Eagle 16 May 2026

... opening a new front against dry eye disease ....

Edit

Too much screen time? New treatment for dry eye disease gets approval in UAE

Khaleejtimes 16 May 2026

The UAE has become the third country to approve Miebo, a new eye drop that treats the dry eye disease, after the Emirates Drug Establishment (EDE) cleared the medication for use in the country.

Edit

UAE becomes world’s 3rd country to approve MIEBO, breakthrough eye drop for dry eye disease

Gulf News 16 May 2026

The Emirates Drug Establishment (EDE) has approved MIEBO by Bausch + Lomb for the treatment of the signs and symptoms of dry eye disease in an effort to enhance patient access in the UAE to the latest ...

Edit

UAE third globally to approve MIEBO as innovative treatment for dry eye disease

Bahrain News 16 May 2026

... patient access in the UAE to the latest pharmaceutical innovations in eye care.

Edit

Eyes that photosynthesise: NUS scientists plant a cure for dry eye disease (NUS - National University of Singapore)

Public Technologies 16 May 2026

NUS scientists plant a cure for dry eye disease ... Dry eye disease, also known as keratoconjunctivitis sicca, is one of the most common eye conditions, affecting more than 1.5 billion people worldwide.

Edit

Study Links Irregular Sleep Schedules to Higher Risk of Eye Diseases

Natural News 13 May 2026

A study of nearly 79,000 adults from the UK Biobank has found that individuals with irregular sleep schedules face higher risks of developing age-rela... .

Edit

Women must steer clear of dry eye disease: Docs

The Times of India 10 May 2026

Comments. +Text SizeSmallMediumLarge. .

Edit

Viridian Therapeutics Announces Positive Topline Results from Elegrobart Phase 3 REVEAL‑2 Clinical Trial in Chronic Thyroid Eye Disease (Zai Lab Ltd)

Public Technologies 05 May 2026

This is an abstract of the document. To keep reading, click here and get access to the original version. Attachments Original document Permalink. Disclaimer ... (noodl. 131495751) .

Edit

Viridian Therapeutics Announces Positive Topline Results from Elegrobart Phase 3 REVEAL-2 Clinical Trial in Chronic Thyroid Eye Disease (Form 8-K) (Viridian Therapeutics Inc)

Public Technologies 05 May 2026

Trial in Chronic Thyroid Eye Disease ... Viridian is advancing multiple late-stage, anti-insulin-like growth factor-1 receptor (IGF-1R) candidates in the clinic for the treatment of patients with thyroid eye disease (TED).

Podcasts:

Latest News for: eye disease

Ethyreal Bio Emerges from Stealth with $101 Million in Financing to Advance ETHY-001, a Potentially Best-in-Class Anti-TSHR Antibody for Thyroid Eye Disease and Graves’ Disease (Avoro Capital Advisors LLC)

Minghui Pharmaceutical Presents Compelling Phase I/II Results for MHB018A, a Novel Subcutaneous Anti-IGF-1R Antibody for Thyroid Eye Disease, in an Oral Presentation at ENDO 2026, the Endocrine Society's Annual Meeting

DKSH and Long Chau Join Forces to Bring Dry Eye Disease Screening to Vietnamese Communities Nationwide (DKSH Holding AG)

New Exhibit Explores Far-Reaching Impact of an Ancient Eye Disease (AAO - American Academy of Ophthalmology)

Eyes that photosynthesize: Scientists plant a cure for dry eye disease

NUS study finds photosynthesis could treat dry eye disease

Eyes that photosynthesise: NUS scientists plant a cure for dry eye disease

Too much screen time? New treatment for dry eye disease gets approval in UAE

UAE becomes world’s 3rd country to approve MIEBO, breakthrough eye drop for dry eye disease

UAE third globally to approve MIEBO as innovative treatment for dry eye disease

Eyes that photosynthesise: NUS scientists plant a cure for dry eye disease (NUS - National University of Singapore)

Study Links Irregular Sleep Schedules to Higher Risk of Eye Diseases

Women must steer clear of dry eye disease: Docs

Viridian Therapeutics Announces Positive Topline Results from Elegrobart Phase 3 REVEAL‑2 Clinical Trial in Chronic Thyroid Eye Disease (Zai Lab Ltd)

Viridian Therapeutics Announces Positive Topline Results from Elegrobart Phase 3 REVEAL-2 Clinical Trial in Chronic Thyroid Eye Disease (Form 8-K) (Viridian Therapeutics Inc)

Article Search

EXPLORE WN.com